作者: Richard B. Taylor , E. C. Henley
DOI:
关键词: Biochanin A 、 Genistein 、 Formononetin 、 Idoxifene 、 Daidzein 、 Raloxifene 、 Pharmacology 、 Selective estrogen receptor modulator 、 Toremifene 、 Chemistry
摘要: The present invention is a composition for preventing, minimizing, or reversing the development growth of breast cancer. contains combination selective estrogen receptor modulator selected from at least one raloxifene, droloxifene, toremifene, 4′-iodotamoxifen, and idoxifene isoflavone genistein, daidzein, biochanin A, formononetin, their respective naturally occurring glucosides glucoside conjugates. also provides method cancer in which co-administered with occuring conjugates to woman having predisposed